These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10205605)

  • 1. Influence of the moisture on the performance of a new dry powder inhaler.
    Maggi L; Bruni R; Conte U
    Int J Pharm; 1999 Jan; 177(1):83-91. PubMed ID: 10205605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physicochemical stability of crystalline sugars and their spray-dried forms: dependence upon relative humidity and suitability for use in powder inhalers.
    Naini V; Byron PR; Phillips EM
    Drug Dev Ind Pharm; 1998 Oct; 24(10):895-909. PubMed ID: 9876544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of some parameters influencing the drug delivery from a dry powder inhalation device using an in vitro model of the horse airways.
    Duvivier DH; Chiap P; Crommen J; Lekeux P
    Vet Res; 1997; 28(6):557-64. PubMed ID: 9428149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clickhaler dry powder inhaler: focussed in vitro proof of principle evaluation of a new chemical entity for asthma.
    Thibert R; Parry-Billings M; Shott M
    Int J Pharm; 2002 Jun; 239(1-2):149-56. PubMed ID: 12052700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle engineering of materials for oral inhalation by dry powder inhalers. II-Sodium cromoglicate.
    Nolan LM; Li J; Tajber L; Corrigan OI; Healy AM
    Int J Pharm; 2011 Feb; 405(1-2):36-46. PubMed ID: 21129460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 1: Grid structure and mouthpiece length.
    Coates MS; Fletcher DF; Chan HK; Raper JA
    J Pharm Sci; 2004 Nov; 93(11):2863-76. PubMed ID: 15389665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dry-powder inhalers: evaluation of testing methodology and effect of inhaler design.
    Broadhead J; Rouan SK; Rhodes CT
    Pharm Acta Helv; 1995 Jul; 70(2):125-31. PubMed ID: 7651970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Acoustic-Based Method to Detect and Quantify the Effect of Exhalation into a Dry Powder Inhaler.
    Holmes MS; Seheult JN; O'Connell P; D'Arcy S; Ehrhardt C; Healy AM; Costello RW; Reilly RB
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):247-53. PubMed ID: 25393346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dry powder aerosol delivery systems: current and future research directions.
    Chan HK
    J Aerosol Med; 2006; 19(1):21-7. PubMed ID: 16551211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moisture transfer into medicament chambers equipped with a double-barrier-desiccant system.
    Lehto VP; Lankinen T
    Int J Pharm; 2004 May; 275(1-2):155-64. PubMed ID: 15081146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of hydrophobic amino acids against moisture-induced deterioration in the aerosolization performance of highly hygroscopic spray-dried powders.
    Yu J; Chan HK; Gengenbach T; Denman JA
    Eur J Pharm Biopharm; 2017 Oct; 119():224-234. PubMed ID: 28655664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of design on the performance of a dry powder inhaler using computational fluid dynamics. Part 2: Air inlet size.
    Coates MS; Chan HK; Fletcher DF; Raper JA
    J Pharm Sci; 2006 Jun; 95(6):1382-92. PubMed ID: 16625656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of sodium stearate on the moisture-induced deterioration of hygroscopic spray-dried powders.
    Yu J; Romeo MC; Cavallaro AA; Chan HK
    Int J Pharm; 2018 Apr; 541(1-2):11-18. PubMed ID: 29454904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highly reproducible powder aerosolisation for lung delivery using powder-specific electromechanical vibration.
    Crowder TM
    Expert Opin Drug Deliv; 2005 May; 2(3):579-85. PubMed ID: 16296776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of budesonide nanocluster dry powder aerosols: formulation and stability.
    El-Gendy N; Huang S; Selvam P; Soni P; Berkland C
    J Pharm Sci; 2012 Sep; 101(9):3445-55. PubMed ID: 22619045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of co-milling techniques for the production of high dose dry powder inhaler formulation.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1229-1238. PubMed ID: 28367654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of dose on the performance of dry powder inhalation systems.
    Young PM; Edge S; Traini D; Jones MD; Price R; El-Sabawi D; Urry C; Smith C
    Int J Pharm; 2005 May; 296(1-2):26-33. PubMed ID: 15885452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.